Search results
Results from the WOW.Com Content Network
Strong Memorial Hospital (SMH) is an 886-bed medical facility, [1] part of the University of Rochester Medical Center complex, in Rochester, New York, United States.Opened in 1926, it is a major provider of both in-patient and out-patient medical services.
“With treatment, almost 100 percent of people can be free of hepatitis C,” says Dr. Menon. The exact treatment you receive will depend on factors including the amount of virus in your body ...
Golisano Children's Hospital (GCH) formerly Children's Hospital at Strong, is a nationally ranked, freestanding acute care children's hospital in Rochester, New York. It is affiliated with the University of Rochester School of Medicine and Dentistry. The hospital has 190 pediatric beds. The hospital provides comprehensive pediatric specialties ...
University of Rochester-Golisano Children's Hospital (GCH) formerly Children's Hospital at Strong, is a nationally ranked, freestanding acute care children's hospital in Rochester, New York. It is affiliated with the University of Rochester School of Medicine and Dentistry. The hospital features all private rooms that consist of 168 pediatric ...
Sofosbuvir/velpatasvir, sold under the brand name Epclusa among others, is a fixed-dose combination medication for the treatment of hepatitis C in adults. [2] [5] [6] [7] It combines sofosbuvir and velpatasvir. [2] [5] [6] It is more than 90% effective for hepatitis C genotypes one through six. [2]
Hepatitis C is an infectious disease caused by the hepatitis C virus (HCV) that primarily affects the liver; [2] it is a type of viral hepatitis. [6] During the initial infection period, people often have mild or no symptoms. [ 1 ]
The DAA drugs against hepatitis C are taken orally, as tablets, for 8 to 12 weeks. [56] The treatment depends on the type or types of hepatitis C virus that are causing the infection. [57] Both during and at the end of treatment, blood tests are used to monitor the effectiveness of the treatment and subsequent cure. [56]
Ledipasvir/sofosbuvir, sold under the trade name Harvoni among others, is a medication used to treat hepatitis C. [8] It is a fixed-dose combination of ledipasvir and sofosbuvir. [8] Cure rates are 94% to 99% in people infected with hepatitis C virus (HCV) genotype 1. [9] Some evidence also supports use in HCV genotype 3 and 4. [9]